Studies have shown that 5-amino-1mq significantly reduces the insulin resistance index and decreases adipocyte size in aging mice, providing new intervention strategies for aging-related metabolic diseases such as type 2 diabetes and obesity
Because robust human safety data are limited, it is difficult to give a definitive side-effect profile with meaningful incidence rates
It is only available through licensed medical providers
No conversion errors
GHK-based formulations, including nanoparticle conjugates, hydrogels, and clinical derivatives such as TriHex and TriHex 2.0, enhance fibroblast migration, ECM remodeling, collagen and elastin synthesis, and wound closure while providing antimicrobial activity
There are no known significant drug interactions at standard research doses